This announcement is a separate document:
自愿披露关于注射用紫杉醇（白蛋白结合型）获得英国上市许可的公告
Voluntary disclosure of the announcement that paclitaxel for injectable use (albumin binding type) has obtained marketing approval in the UK
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated